TANDEM DIABETES Aktie

>TANDEM DIABETES Aktienkurs

19.23 EUR -2.9% (Tradegate)

Ask: 19.23 EUR / 1100 Stück

Bid: 19.13 EUR / 1100 Stück

Tagesumsatz: 129 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>TANDEM DIABETES Performance

1 Woche: +0,6%

1 Monat: +2,0%

3 Monate: +84,8%

6 Monate: +15,4%

1 Jahr: -45,3%

laufendes Jahr: -45,3%

>TANDEM DIABETES Aktie

Name:

TANDEM DIABETES NEW -,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US8753722037 / A2H5BX

Symbol/ Ticker:

TD5A (Frankfurt) / TNDM (NASDAQ)

Kürzel:

FRA:TD5A, ETR:TD5A, TD5A:GR, NASDAQ:TNDM

Index:

Webseite:

https://www.tandemdiabete..

Profil:

Tandem Diabetes Care Inc. is a medical device comp..
>Volltext..

Marktkapitalisierung:

1337.24 Mio. EUR

Unternehmenswert:

1447.87 Mio. EUR

Umsatz:

853.86 Mio. EUR

EBITDA:

-68.47 Mio. EUR

Nettogewinn:

-172.44 Mio. EUR

Gewinn je Aktie:

-2.59 EUR

Schulden:

380.96 Mio. EUR

Liquide Mittel:

77.96 Mio. EUR

Operativer Cashflow:

-7.46 Mio. EUR

Bargeldquote:

1.26

Umsatzwachstum:

11.84%

Gewinnwachstum:

-52.2%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

TANDEM DIABETES

Letzte Datenerhebung:

26.12.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 67.8 Mio. St.

Frei handelbar: 98.94%

Leerverk. Aktien: 12.06%

Rückkaufquote: 0.18%

Mitarbeiter: 2650

Umsatz/Mitarb.: 0.3 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 15%

Bewertung:

KGV: -

KGV lG: -

KUV: 1.43

KBV: 10.81

PEG-Ratio: -0.12

EV/EBITDA: -

Rentabilität:

Bruttomarge: 53.23%

Gewinnmarge: -20.2%

Operative Marge: -9.75%

Managementeffizenz:

Gesamtkaprendite: -22.2%

Eigenkaprendite: -109.73%

>Peer Group

Es sind 599 Aktien bekannt.

>TANDEM DIABETES Chart & Kurs - NASDAQ

>TANDEM DIABETES News

26.12.25 - 00:27	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Dec. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

18.12.25 - 00:12	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

12.12.25 - 16:36	Don′t Buy Tandem Diabetes Care Until This Big Thing Happens (Fool)
	The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism....

11.12.25 - 22:51	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

09.12.25 - 15:01	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
	TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance....

05.12.25 - 21:51	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

03.12.25 - 23:24	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

28.11.25 - 18:51	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Nov. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

17.11.25 - 08:06	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

12.11.25 - 02:12	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

11.11.25 - 18:42	Tandem Diabetes auf der Stifel-Konferenz 2025: Strategie für Wachstum und Marktexpansion (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.25 - 03:21	Tandem Diabetes Care outlines path to $1B sales milestone and gross margin gains in 2025 while expanding pharmacy channel (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.25 - 01:45	Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
	Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

07.11.25 - 01:00	Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
	Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 0.00% and +4.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.11.25 - 00:09	Tandem Diabetes Care soars after double Q3 beats (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 22:24	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

31.10.25 - 23:30	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

30.10.25 - 16:30	Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
	Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

26.10.25 - 14:03	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
	NEW YORK, Oct. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......

23.10.25 - 17:18	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM (PR Newswire)
	NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Qualität des Lebens findet auf der letzten Ruhestätte ihren Niederschlag. - Elisabeth Schöffl-Pöll

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram